Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Journal of Alzheimer'S Disease : JAD|November 26, 2023
How Can We Use Mathematical Modeling of Amyloid-β in Alzheimer's Disease Research and Clinical Practices?Chenyin Chu, Yi Ling Clare Low, Liwei Ma, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2025
Exploring epidemiological risk factors for cerebral amyloid angiopathy: Considerations for monoclonal antibody therapy in people with Alzheimer's diseaseLiwei Ma, Yihan Wang, Andrew Liem Hieu Huynh, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 21, 2024
Exploring the link between comorbidities and Alzheimer's dementia in the Australian Imaging, Biomarker & Lifestyle (AIBL) studyCatherine Quynh Nhu Nguyen, Liwei Ma, Yi Ling Clare Low, et al.
Advanced Drug Delivery Reviews|April 14, 2022
Altered peripheral factors affecting the absorption, distribution, metabolism, and excretion of oral medicines in Alzheimer's diseaseElka S Waller, Ben J Yardeny, Wan Yun Fong, et al.
Brain, Behavior, and Immunity|March 17, 2018
Cognitive benefits of lithium chloride in APP/PS1 mice are associated with enhanced brain clearance of β-amyloidYijun Pan, Jennifer L Short, Stephanie A Newman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2025
Predicting severity of cerebral amyloid angiopathy neuropathology: A modeling approach using NACC and ROSMAP dataChenyin Chu, Liwei Ma, Yihan Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2025
Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severityChenyin Chu, Yihan Wang, Liwei Ma, et al.
Journal of Pharmaceutical Sciences|November 12, 2021
Blockade of Microglial Kv1.3 Potassium Channels by the Peptide HsTX1[R14A] Attenuates Lipopolysaccharide-mediated NeuroinflammationJoseph A Nicolazzo, Yijun Pan, Ilenia Di Stefano, et al.
Pageof 9